- Home
- OIS vs VNDA Comparison
OIS vs VNDA Comparison
Compare OIS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- VNDA
- Stock Information
- Founded
- OIS 1995
- VNDA 2002
- Country
- OIS United States
- VNDA United States
- Employees
- OIS N/A
- VNDA N/A
- Industry
- OIS Metal Fabrications
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- VNDA Health Care
- Exchange
- OIS Nasdaq
- VNDA Nasdaq
- Market Cap
- OIS 285.8M
- VNDA 261.7M
- IPO Year
- OIS 2001
- VNDA 2006
- Fundamental
- Price
- OIS $5.36
- VNDA $4.92
- Analyst Decision
- OIS Buy
- VNDA Strong Buy
- Analyst Count
- OIS 3
- VNDA 3
- Target Price
- OIS $6.17
- VNDA $15.33
- AVG Volume (30 Days)
- OIS 830.6K
- VNDA 410.1K
- Earning Date
- OIS 07-28-2025
- VNDA 07-30-2025
- Dividend Yield
- OIS N/A
- VNDA N/A
- EPS Growth
- OIS N/A
- VNDA N/A
- EPS
- OIS 0.08
- VNDA N/A
- Revenue
- OIS $685,264,000.00
- VNDA $201,351,000.00
- Revenue This Year
- OIS $2.14
- VNDA $16.86
- Revenue Next Year
- OIS $6.71
- VNDA $39.78
- P/E Ratio
- OIS $66.07
- VNDA N/A
- Revenue Growth
- OIS N/A
- VNDA 13.37
- 52 Week Low
- OIS $3.08
- VNDA $3.81
- 52 Week High
- OIS $5.86
- VNDA $6.37
- Technical
- Relative Strength Index (RSI)
- OIS 61.20
- VNDA 65.48
- Support Level
- OIS $5.13
- VNDA $4.38
- Resistance Level
- OIS $5.81
- VNDA $4.63
- Average True Range (ATR)
- OIS 0.23
- VNDA 0.16
- MACD
- OIS 0.00
- VNDA 0.01
- Stochastic Oscillator
- OIS 64.00
- VNDA 96.70
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.